[1]
2026. Reduced Mucosal Inflammation and Select Alterations in the Viable Mucosa-Associated Microbiota Observed in Clinically-Responsive Ulcerative Colitis Patients Following A Single Fecal Microbiota Transplantation in a Pilot Study Evaluating Safety and Efficac. Journal of Clinical Nutrition and Food Science. 3, 1 (Jul. 2026).